Patient Access to ESRD New Innovative Devices Act

Summary

Patient Access to ESRD New Innovative Devices Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must provide for a three-year temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD. (CMS regulations currently provide a two-year temporary add-on payment adjustment.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 22 September 2021

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

2. 22 September 2021

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 22 September 2021

   Introduced

   Introduced in House

   Source: IntroReferral

4. 22 September 2021

   Introduced

   Introduced in House

   Source: IntroReferral

5. 23 September 2021

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 22 September 2021 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 22 September 2021

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 22 September 2021

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 22 September 2021

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Davis, Danny K. [D-IL-7] · D · Sponsor
• Rep. Rush, Bobby L. [D-IL-1] · D · Sponsor
• Rep. Wenstrup, Brad R. [R-OH-2] · R · Sponsor
• Rep. Hollingsworth, Trey [R-IN-9] · R · Sponsor
• · hsif00 · Standing
• · hswm00 · Standing

Related records

• related to → Patient Access to ESRD New Innovative Devices Act
• related to → Patient Access to ESRD New Innovative Devices Act